Cooperative Framework for Clinical Trial Model Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The extraction and manipulation of clinical trial data from databases are resource-intensive and inefficient, particularly when evaluating multiple models for predicting disease progression, as existing competitive frameworks require exponentially increasing computing resources with the number of models evaluated.
Innovation Solution
A cooperative framework with competitive elements is implemented, using linear combinations of models and gradient descent techniques to evaluate the coefficients of individual models, reducing resource usage to a linear rate and enabling the identification of model combinations that predict disease progression effectively.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional competitive frameworks are used to evaluate multiple models for predicting disease progression, then model evaluation accuracy can be maintained, but computing resource requirements increase exponentially with the number of models evaluated
Solution Approach 1:
The patent combines multiple competing models into a single ensemble model that integrates their predictions. Instead of evaluating each model separately through multiple clinical trials, the ensemble model aggregates predictions from individual models (e.g., using weighted averages or voting mechanisms), allowing simultaneous evaluation of multiple models while reducing computational overhead to linear scaling with the number of models.
Solution Approach 2:
The ensemble modeling framework serves multiple functions: it evaluates multiple individual models concurrently, produces a consolidated prediction, and reduces computational resource requirements. This multi-functional approach allows the system to maintain measurement precision across multiple models while using a single unified evaluation process rather than separate competitive frameworks for each model.
2Productivity
If multiple models are evaluated using traditional competitive frameworks, then comprehensive model assessment is achieved, but the number of clinical trials required increases exponentially
Solution Approach 1:
Multiple models are merged into an ensemble structure that can be evaluated through a single clinical trial or fewer trials. The ensemble model integrates predictions from multiple individual models, allowing comprehensive assessment of all models simultaneously rather than requiring separate trials for each model, thus reducing the total number of trials needed from exponential to linear or constant scaling.
Solution Approach 2:
The framework performs preliminary integration of multiple models into an ensemble structure before conducting clinical trials. By pre-combining models with appropriate weighting or aggregation rules, the system prepares a unified evaluation framework that assesses multiple models concurrently during the trial, avoiding the need to conduct separate trials for each model afterward.
3Measurement precision
If individual models are evaluated separately, then model-specific performance can be analyzed, but overall resource consumption and evaluation time increase
Solution Approach 1:
The ensemble model merges individual model evaluations into a unified framework where each model's performance can still be analyzed separately through its contribution to the ensemble prediction. The system maintains the ability to assess individual model performance (e.g., through feature importance, weight analysis, or component-wise evaluation) while conducting all evaluations simultaneously within a single trial, reducing total evaluation time from sequential to parallel processing.
Data Source
AI summary
This disclosure describes frameworks and techniques directed to the analysis and verification of models extracted from a database. In some cases, the database can include an online database, such as clinicaltrials.gov administered by the United States National Institutes of Health. In particular, this disclosure describes implementations that utilize models derived from clinical trial data extracted from a database and analyzes the models. The analysis of the models can be used to verify the results of the clinical trials from which the models were derived. Additionally, the analysis of the models can identify a combination of models that can be used to predict health outcomes of one or more biological conditions for one or more populations.